These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36515045)

  • 61. New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.
    Spengler G; Kincses A; Gajdács M; Amaral L
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28294992
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biocide Selective TolC-Independent Efflux Pumps in Enterobacteriaceae.
    Slipski CJ; Zhanel GG; Bay DC
    J Membr Biol; 2018 Feb; 251(1):15-33. PubMed ID: 29063140
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics.
    Schindler BD; Jacinto P; Kaatz GW
    Future Microbiol; 2013 Apr; 8(4):491-507. PubMed ID: 23534361
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
    Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline.
    McAleese F; Petersen P; Ruzin A; Dunman PM; Murphy E; Projan SJ; Bradford PA
    Antimicrob Agents Chemother; 2005 May; 49(5):1865-71. PubMed ID: 15855508
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The hydrophobic trap-the Achilles heel of RND efflux pumps.
    Aron Z; Opperman TJ
    Res Microbiol; 2018; 169(7-8):393-400. PubMed ID: 29146106
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Efflux-mediated antimicrobial multidrug resistance].
    Jarmuła A; Obłąk E; Wawrzycka D; Gutowicz J
    Postepy Hig Med Dosw (Online); 2011 Apr; 65():216-27. PubMed ID: 21502698
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus.
    Zimmermann S; Tuchscherr L; Rödel J; Löffler B; Bohnert JA
    J Microbiol Methods; 2017 Nov; 142():39-40. PubMed ID: 28887002
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C
    ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains.
    Dos Santos Barbosa CR; Scherf JR; de Freitas TS; de Menezes IRA; Pereira RLS; Dos Santos JFS; de Jesus SSP; Lopes TP; de Sousa Silveira Z; de Morais Oliveira-Tintino CD; Júnior JPS; Coutinho HDM; Tintino SR; da Cunha FAB
    J Bioenerg Biomembr; 2021 Aug; 53(4):489-498. PubMed ID: 34159523
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mutagenesis and modeling to predict structural and functional characteristics of the Staphylococcus aureus MepA multidrug efflux pump.
    Schindler BD; Patel D; Seo SM; Kaatz GW
    J Bacteriol; 2013 Feb; 195(3):523-33. PubMed ID: 23175649
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potentiating activity of Norfloxacin by synthetic chalcones against NorA overproducing Staphylococcus aureus.
    Alves Borges Leal AL; Teixeira da Silva P; Nunes da Rocha M; Marinho EM; Marinho ES; Marinho MM; Bandeira PN; Sampaio Nogueira CE; Barreto HM; Rodrigues Teixeira AM; Silva Dos Santos H
    Microb Pathog; 2021 Jun; 155():104894. PubMed ID: 33894291
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis, antibiotic modifying activity, ADMET study and molecular docking of chalcone (E)-3-(2,4-dichlorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying MepA efflux pumps.
    Rocha JE; de Freitas TS; da Cunha Xavier J; Pereira RLS; Pereira FN; Nogueira CES; Marinho MM; Bandeira PN; Fernandes MAA; Marinho ES; Teixeira AMR; Dos Santos HS; Coutinho HDM
    Arch Microbiol; 2021 Dec; 204(1):63. PubMed ID: 34940944
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Liposome evaluation in inhibiting pump efflux of NorA of Staphylococcus aureus.
    Júnior JGAS; Coutinho HDM; Rodrigues JPV; Ferreira VPG; Neto JBA; Costa da Silva MM; Justino de Araújo AC; Pereira RLS; Alexandre de Aquino PE; Oliveira-Tintino CDM; Nicolete R
    Chem Phys Lipids; 2022 Jul; 245():105204. PubMed ID: 35398337
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antibacterial and antibiotic modifying activity, ADMET study and molecular docking of synthetic chalcone (E)-1-(2-hydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying NorA and MepA efflux pumps.
    Rocha JE; de Freitas TS; da Cunha Xavier J; Pereira RLS; Junior FNP; Nogueira CES; Marinho MM; Bandeira PN; de Oliveira MR; Marinho ES; Teixeira AMR; Dos Santos HS; Coutinho HDM
    Biomed Pharmacother; 2021 Aug; 140():111768. PubMed ID: 34058442
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Unraveling the ligand specificity and promiscuity of the
    Işık EB; Serçinoğlu O
    J Biomol Struct Dyn; 2024 Mar; ():1-12. PubMed ID: 38497784
    [No Abstract]   [Full Text] [Related]  

  • 77. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
    Fontaine F; Hequet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    J Med Chem; 2014 Mar; 57(6):2536-48. PubMed ID: 24499135
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel insight into antimicrobial resistance and sensitivity phenotypes associated to qac and norA genotypes in Staphylococcus aureus.
    Marchi E; Furi L; Arioli S; Morrissey I; Di Lorenzo V; Mora D; Giovannetti L; Oggioni MR; Viti C
    Microbiol Res; 2015 Jan; 170():184-94. PubMed ID: 25081379
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
    Felicetti T; Cannalire R; Pietrella D; Latacz G; Lubelska A; Manfroni G; Barreca ML; Massari S; Tabarrini O; Kieć-Kononowicz K; Schindler BD; Kaatz GW; Cecchetti V; Sabatini S
    J Med Chem; 2018 Sep; 61(17):7827-7848. PubMed ID: 30067360
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.
    Astolfi A; Felicetti T; Iraci N; Manfroni G; Massari S; Pietrella D; Tabarrini O; Kaatz GW; Barreca ML; Sabatini S; Cecchetti V
    J Med Chem; 2017 Feb; 60(4):1598-1604. PubMed ID: 28117588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.